Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Plos One
|
May 12, 2011
Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization
Hani Salehi-Had, Mi In Roh, Andrea Giani, et al.
Ophthalmology Science
|
June 6, 2022
Machine learning OCT predictors of progression from intermediate age-related macular degeneration to geographic atrophy and vision loss
Eleonora Lad, Karim Sleiman, David L Banks, et al.
Ophthalmology Science
|
July 14, 2025
HORNBILL: A First-in-Human Phase I/IIa Study of the Safety, Tolerability, and Early Pharmacodynamics of BI 764524 for Diabetic Macular Ischemia
Quan Dong Nguyen, Chirag Jhaveri, Maged Habib, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
October 3, 2015
Choroidal Thickness in Eyes With Central Geographic Atrophy Secondary to Stargardt Disease and Age-Related Macular Degeneration
Renata Portella Nunes, Potyra R Rosa, Andrea Giani, et al.
The American Journal of Pathology
|
March 21, 2012
Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse
Aristomenis Thanos, Yuki Morizane, Yusuke Murakami, et al.
Investigative Ophthalmology & Visual Science
|
August 13, 2025
Evaluating the Progression of Retinal Sensitivity Loss in Geographic Atrophy Using Machine-Learning-Based Structure-Function Correlation (OMEGA 2)
Georg Ansari, Nils Schärer, Kristina Pfau, et al.
Ophthalmic Research
|
November 28, 2023
The Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients with Geographic Atrophy (OMEGA) Study: Design and Baseline Characteristics - OMEGA Report 1
Georg Ansari, Nils Schärer, Hanna Camenzind Zuche, et al.
Ophthalmology Science
|
June 30, 2026
Tropomyosin-Related Kinase Receptor Type B Agonism in Geographic Atrophy-The Translational Challenges from Preclinical Data to a First-in-Human Trial
David Brown, Oliver Zeitz, Clare Bailey, et al.
Eye (London, England)
|
December 15, 2023
Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3
Shruti Chandra, Sarega Gurudas, Ian Pearce, et al.
Acta Ophthalmologica
|
March 8, 2026
The optical coherence tomography and microperimetry biomarker evaluation in patients with geographic atrophy (OMEGA) study: Geographic atrophy progression in fundus autofluorescence - OMEGA report 3
Philippe Valmaggia, Georg Ansari, Nadja Inglin, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Plos One
|
May 12, 2011
Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization
Hani Salehi-Had, Mi In Roh, Andrea Giani, et al.
Ophthalmology Science
|
June 6, 2022
Machine learning OCT predictors of progression from intermediate age-related macular degeneration to geographic atrophy and vision loss
Eleonora Lad, Karim Sleiman, David L Banks, et al.
Ophthalmology Science
|
July 14, 2025
HORNBILL: A First-in-Human Phase I/IIa Study of the Safety, Tolerability, and Early Pharmacodynamics of BI 764524 for Diabetic Macular Ischemia
Quan Dong Nguyen, Chirag Jhaveri, Maged Habib, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
October 3, 2015
Choroidal Thickness in Eyes With Central Geographic Atrophy Secondary to Stargardt Disease and Age-Related Macular Degeneration
Renata Portella Nunes, Potyra R Rosa, Andrea Giani, et al.
The American Journal of Pathology
|
March 21, 2012
Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse
Aristomenis Thanos, Yuki Morizane, Yusuke Murakami, et al.
Investigative Ophthalmology & Visual Science
|
August 13, 2025
Evaluating the Progression of Retinal Sensitivity Loss in Geographic Atrophy Using Machine-Learning-Based Structure-Function Correlation (OMEGA 2)
Georg Ansari, Nils Schärer, Kristina Pfau, et al.
Ophthalmic Research
|
November 28, 2023
The Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients with Geographic Atrophy (OMEGA) Study: Design and Baseline Characteristics - OMEGA Report 1
Georg Ansari, Nils Schärer, Hanna Camenzind Zuche, et al.
Ophthalmology Science
|
June 30, 2026
Tropomyosin-Related Kinase Receptor Type B Agonism in Geographic Atrophy-The Translational Challenges from Preclinical Data to a First-in-Human Trial
David Brown, Oliver Zeitz, Clare Bailey, et al.
Eye (London, England)
|
December 15, 2023
Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3
Shruti Chandra, Sarega Gurudas, Ian Pearce, et al.
Acta Ophthalmologica
|
March 8, 2026
The optical coherence tomography and microperimetry biomarker evaluation in patients with geographic atrophy (OMEGA) study: Geographic atrophy progression in fundus autofluorescence - OMEGA report 3
Philippe Valmaggia, Georg Ansari, Nadja Inglin, et al.
Page
of 6